How did IDNA's Momentum indicator behave recently?

The Momentum Indicator moved above the 0 level on December 22, 2025. You may want to consider a long position or call options on IDNA as a result. In 75 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

What does a 3-day price advance indicate for IDNA?

Following a +3.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where IDNA advanced for three days, in 239 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

IDNA

AS OF

Dec 24 closing price

Price

$26.94

Change

+$0.15 (+0.56%)

Net Assets

134.8M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

IDNA

ETF ticker: NYSE ARCA

AS OF

Dec 24 closing price

Price

$26.94

Change

+$0.15 (+0.56%)

Net Assets

134.8M

IDNA stock forecast, quote, news & analysis

Q: How does the Aroon Indicator reflect on IDNA's trend?

The Aroon Indicator entered an Uptrend today. In 179 of 206 cases where IDNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.

The investment seeks to track the investment results of the NYSE® FactSet® Global Genomics and Immuno Biopharma IndexTM... Show more

Category: #Health

Get AI intraday signals

IDNA

Setup

Daily Signal:

Description

Gain/Loss:

A.I.Advisor

published price charts

These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.

View AI-Driven Trading for IDNA

Interact to see
Advertisement

A.I.Advisor

a Summary for IDNA with price predictions

Dec 24, 2025

IDNA sees MACD Histogram just turned negative

IDNA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 02, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IDNA moved out of overbought territory on December 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 22, 2025. You may want to consider a long position or call options on IDNA as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IDNA advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 206 cases where IDNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor

published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX).

Industry description

The investment seeks to track the investment results of the NYSE® FactSet® Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

Market Cap

The average market capitalization across the iShares Genomics Immnlgy & Hlthcr ETF ETF is 24.45B. The market cap for tickers in the group ranges from 149.74M to 287.74B. AZN holds the highest valuation in this group at 287.74B. The lowest valued company is SGMO at 149.74M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Genomics Immnlgy & Hlthcr ETF ETF was 4%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 30%. MREO experienced the highest price growth at 20%, while FDMT experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the iShares Genomics Immnlgy & Hlthcr ETF ETF was -54%. For the same stocks of the ETF, the average monthly volume growth was -56% and the average quarterly volume growth was -71%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54

P/E Growth Rating: 76

Price Growth Rating: 49

SMR Rating: 81

Profit Risk Rating: 83

Seasonality Score: -3 (-100 ... +100)

View a ticker or compare two or three

Compare

IDNA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I. Advisor

published General Information

General Information

Category Health

Profile

Fundamentals

Details